We met some of the brilliant women from the BartsMS research group at Queen Mary University London. Dr Sharmilee Gnanapavan is a neurologist who specialises in finding new ways of identifying MS progression.
It takes a long time and lots of hard work to develop a new MS treatment. In 2019, ocrelizumab (brand name Ocrevus) became the first drug to be available for people with primary progressive MS on the NHS.
To help people at every stage of MS, we need to stop MS from progressing. Researchers are looking at three ways to do this. And we’ve now reached the point where there are clinical trials in progress for all three.
Recent media reports suggest testosterone plays a role in protecting men against MS. We look behind the headlines to see what the study actually showed.
